ApicHope Pharmaceutical Co., Ltd

SZSE:300723.SZ

26.51 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q4
Revenue 320.632283.646622.871653.636584.1549.709716.002665.339709.753389.4515.707546.018700.015438.424514.757481.348543.362311.387339.32446.298418.069436.883336.155346.255315.717396.55371.033342.364367.235386.788283.83361.615
Cost of Revenue 161.916132.376150.913125.835139.723108.247100.77587.85497.20362.72352.42565.851113.370.94668.36578.19895.47172.749.059112.76174.776113.67165.82267.30351.279132.083142.807121.348169.84173.391115.331157.794
Gross Profit 158.716151.27471.958527.801444.376441.462615.227577.485612.55326.678463.282480.167586.715367.478446.392403.151447.891238.687290.261333.538343.293323.212270.333278.952264.438264.467228.225221.016197.396213.397168.499203.821
Gross Profit Ratio 0.4950.5330.7580.8070.7610.8030.8590.8680.8630.8390.8980.8790.8380.8380.8670.8380.8240.7670.8550.7470.8210.740.8040.8060.8380.6670.6150.6460.5380.5520.5940.564
Reseach & Development Expenses 58.10472.98862.529124.71746.39982.1348.12272.60547.10835.82534.24342.65947.03225.57127.06169.0127.76522.20116.36844.86612.95916.18824.03534.27826.19817.84113.066121.27418.33622.719046.967
General & Administrative Expenses 0-31.70865.777-49.799153.047-22.77551.418-63.586104.081-14.11637.704-48.0183.895-17.07933.706-54.15725.099-5.20415.637-25.55720.921-3.81314.076-32.3418.839-54.79526.77-63.1214.182-10.87123.058-45.986
Selling & Marketing Expenses 099.74216.106261.961236.533235.217389.791363.404381.381206.126297.943326.372392.527258.502304.279303.223294.751146.865189.619222.279236.562222.554169.716137.092155.541170.56150.88399.175110.748122.857106.696103.165
SG&A 110.984132.051281.883212.162389.58212.441441.209299.818485.462192.01335.647278.361476.423241.422337.984249.066319.85141.661205.256196.722257.483218.741183.792104.752174.38115.765177.65336.055124.93111.987129.75557.179
Other Expenses 0-3.133-2.493-12.117-0.99642.0371.33-15.0618.42123.7664.84390.159.6981.603-0.00274.453-0.7086.07-5.072.1124.988-0.3260.0154.5090.5043.881-0.016-6.9111.016.3853.6797.611
Operating Expenses 169.088205.039347.009539.641342.928392.077479.562506.76501.561264.391373.327497.604427.01307.886369.442454.014301.69201.54223.812303.081273.446257.911208.914196.929202.01214.547181.153157.158146.676159.87132.817153.06
Operating Income -10.372-53.769114.188-54.855101.49741.775125.51330.009114.03855.32882.599-20.717173.57758.29474.128-47.007148.55839.39157.612-19.02670.56969.28261.44283.52558.79747.04345.46657.31146.10946.83731.4444.427
Operating Income Ratio -0.032-0.190.183-0.0840.1740.0760.1750.0450.1610.1420.16-0.0380.2480.1330.144-0.0980.2730.1270.17-0.0430.1690.1590.1830.2410.1860.1190.1230.1670.1260.1210.1110.123
Total Other Income Expenses Net -292.493-20.174-2.493-12.117-0.99642.0371.33-2.59118.42123.7664.84366.199.6981.603-0.00274.453-0.7086.07-5.072.1124.988-0.3260.0154.5090.5043.881-0.016-6.9111.015.573.6797.316
Income Before Tax -302.866-73.943111.695-66.972100.50183.812126.84327.418132.45979.09487.44245.473183.27559.89774.12727.446147.8545.46152.542-16.91475.55768.95661.45788.03359.30150.92445.4550.447.11952.40735.11951.742
Income Before Tax Ratio -0.945-0.2610.179-0.1020.1720.1520.1770.0410.1870.2030.170.0830.2620.1370.1440.0570.2720.1460.155-0.0380.1810.1580.1830.2540.1880.1280.1220.1470.1280.1350.1240.143
Income Tax Expense -2.387-9.4916.20840.5931.316-1.98322.46712.06327.5910.9213.74416.48335.99310.4496.432-0.08931.7838.6229.3458.32715.02810.86612.30713.2787.6448.3516.754.0599.38611.195.5916.034
Net Income -292.997-54.054100.512-97.33977.01693.831111.10624.719111.3674.8179.79318.617170.33849.9268.04129.01116.14437.20443.252-24.0860.52158.09349.15274.91651.80242.80738.69946.60139.22441.22229.64946.239
Net Income Ratio -0.914-0.1910.161-0.1490.1320.1710.1550.0370.1570.1920.1550.0340.2430.1140.1320.060.2140.1190.127-0.0540.1450.1330.1460.2160.1640.1080.1040.1360.1070.1070.1040.128
EPS -0.65-0.120.22-0.250.170.220.260.0590.270.180.190.0440.390.120.160.0660.270.0870.1-0.0570.140.140.110.170.120.0960.0890.130.120.130.0920.14
EPS Diluted -0.65-0.120.22-0.250.170.220.260.0590.270.180.180.0440.390.120.160.0660.270.0870.1-0.0570.140.140.110.170.120.0960.0890.130.120.130.0920.14
EBITDA -298.2370.314124.001-28.45688.79690.933136.99837.56131.3889.80894.07985.529172.3464.05279.50227.659148.91146.53361.94537.99877.54968.87663.439101.72363.94957.3847.07363.66651.77160.18835.68273.026
EBITDA Ratio -0.930.0010.199-0.0440.1520.1650.1910.0560.1850.2310.1820.1570.2460.1460.1540.0570.2740.1490.1830.0850.1850.1580.1890.2940.2030.1450.1270.1860.1410.1560.1260.202